Publications

View full list on Google Scholar →

• 2026

  Harnessing genomics for early cancer detection, risk stratification and prevention

  M. Gu, W. Z. Zhang, R. C. Fitzgerald, A. M. Frankell*, G. S. Vassiliou (*joint corresponding author)

  Nature Genetics, 58(4), 704–716

  ReviewEarly detection DOI
• 2025

  Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction

  J. R. M. Black, … A. M. Frankell*, C. Swanton (*joint senior author)

  Cell, 188(25), 7083–7098

  ctDNALung cancer DOI
• 2025

  Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma

  J. R. M. Black, … M. Jamal-Hanjani, A. M. Frankell*, C. Swanton (*joint senior author)

  Nature Medicine, 31(1), 70–76

  ctDNAEarly detection DOI
• 2023

  The evolution of lung cancer and impact of subclonal selection in TRACERx

  A. M. Frankell*, M. Dietzen, M. Al Bakir, … C. Swanton (*joint first author)

  Nature, 616, 525–533

  SelectionTRACERxLung cancer DOI
• 2023

  Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

  C. Abbosh*, A. M. Frankell*, … C. Swanton (*joint first author)

  Nature, 616, 553–562

  ctDNAMetastasisTRACERx DOI
• 2021

  Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling

  E. Ococks*, A. M. Frankell*, … E. C. Smyth (*joint first author)

  Annals of Oncology, 32(4), 522–532

  ctDNAOesophageal cancer DOI
• 2019

  The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic

  A. M. Frankell, S. Jammula, … R. C. Fitzgerald

  Nature Genetics, 51, 506–516

  SelectionOesophageal cancerBiomarkers DOI